BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9730223)

  • 1. A rational strategy for enhancing the affinity of vancomycin towards depsipeptide ligands.
    Axelsen PH; Li D
    Bioorg Med Chem; 1998 Jul; 6(7):877-81. PubMed ID: 9730223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants for differential effects on D-Ala-D-lactate vs D-Ala-D-Ala formation by the VanA ligase from vancomycin-resistant enterococci.
    Lessard IA; Healy VL; Park IS; Walsh CT
    Biochemistry; 1999 Oct; 38(42):14006-22. PubMed ID: 10529248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deconstructing vancomycin.
    Walsh C
    Science; 1999 Apr; 284(5413):442-3. PubMed ID: 10232990
    [No Abstract]   [Full Text] [Related]  

  • 4. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.
    Ge M; Chen Z; Onishi HR; Kohler J; Silver LL; Kerns R; Fukuzawa S; Thompson C; Kahne D
    Science; 1999 Apr; 284(5413):507-11. PubMed ID: 10205063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural biology of molecular recognition by vancomycin.
    Loll PJ; Axelsen PH
    Annu Rev Biophys Biomol Struct; 2000; 29():265-89. PubMed ID: 10940250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of configurational entropy in biochemical cooperativity.
    Jusuf S; Loll PJ; Axelsen PH
    J Am Chem Soc; 2002 Apr; 124(14):3490-1. PubMed ID: 11929222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 19F NMR in the measurement of binding affinities of chloroeremomycin to model bacterial cell-wall surfaces that mimic VanA and VanB resistance.
    Entress RM; Dancer RJ; O'Brien DP; Try AC; Cooper MA; Williams DH
    Chem Biol; 1998 Jun; 5(6):329-37. PubMed ID: 9653551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers.
    Cooper MA; Fiorini MT; Abell C; Williams DH
    Bioorg Med Chem; 2000 Nov; 8(11):2609-16. PubMed ID: 11092546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin binding to low-affinity ligands: delineating a minimum set of interactions necessary for high-affinity binding.
    Loll PJ; Kaplan J; Selinsky BS; Axelsen PH
    J Med Chem; 1999 Nov; 42(22):4714-9. PubMed ID: 10579833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A trivalent system from vancomycin.D-ala-D-Ala with higher affinity than avidin.biotin.
    Rao J; Lahiri J; Isaacs L; Weis RM; Whitesides GM
    Science; 1998 May; 280(5364):708-11. PubMed ID: 9563940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
    Ślusarz R; Szulc M; Madaj J
    Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
    Leimkuhler C; Chen L; Barrett D; Panzone G; Sun B; Falcone B; Oberthür M; Donadio S; Walker S; Kahne D
    J Am Chem Soc; 2005 Mar; 127(10):3250-1. PubMed ID: 15755121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MM 45289, a potent glycopeptide antibiotic which interacts weakly with diacetyl-L-lysyl-D-alanyl-D-alanine.
    Good VM; Gwynn MN; Knowles DJ
    J Antibiot (Tokyo); 1990 May; 43(5):550-5. PubMed ID: 2113517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First principles investigation of vancomycin and teicoplanin binding to bacterial cell wall termini.
    Lee JG; Sagui C; Roland C
    J Am Chem Soc; 2004 Jul; 126(27):8384-5. PubMed ID: 15237988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface Ligand Density of Antibiotic-Nanoparticle Conjugates Enhances Target Avidity and Membrane Permeabilization of Vancomycin-Resistant Bacteria.
    Hassan MM; Ranzoni A; Phetsang W; Blaskovich MA; Cooper MA
    Bioconjug Chem; 2017 Feb; 28(2):353-361. PubMed ID: 27959504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Alanyl-D-lactate and D-alanyl-D-alanine synthesis by D-alanyl-D-alanine ligase from vancomycin-resistant Leuconostoc mesenteroides. Effects of a phenylalanine 261 to tyrosine mutation.
    Park IS; Walsh CT
    J Biol Chem; 1997 Apr; 272(14):9210-4. PubMed ID: 9083053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions.
    McComas CC; Crowley BM; Boger DL
    J Am Chem Soc; 2003 Aug; 125(31):9314-5. PubMed ID: 12889959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronized conformational fluctuations and binding site desolvation during molecular recognition.
    Jusuf S; Axelsen PH
    Biochemistry; 2004 Dec; 43(49):15446-52. PubMed ID: 15581356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel glycopeptide antibiotics: N-alkylated derivatives active against vancomycin-resistant enterococci.
    Rodriguez MJ; Snyder NJ; Zweifel MJ; Wilkie SC; Stack DR; Cooper RD; Nicas TI; Mullen DL; Butler TF; Thompson RC
    J Antibiot (Tokyo); 1998 Jun; 51(6):560-9. PubMed ID: 9711219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of oritavancin and related glycopeptide antibiotics.
    Allen NE; Nicas TI
    FEMS Microbiol Rev; 2003 Jan; 26(5):511-32. PubMed ID: 12586393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.